Introduction HAMSYL 3750IU INJECTION:

Hamsyl 3750IU Injection is a chemotherapy drug containing the active constituent Pegaspargase. It is used to treat a type of blood cancer called Acute Lymphoblastic Leukemia (ALL). This is a white blood cell cancer in which the immature white cells start growing out of control, thus preventing the production of functional blood cells. Combined with other chemotherapy drugs, this medication can help increase the chances of remission and long-term survival for people with ALL. It is particularly effective in treating children with ALL, who have a higher remission rate and overall survival when included in their treatment plan.

Hamsyl 3750IU Injection is typically used with other chemotherapy agents to treat ALL, particularly in patients who have not responded to other treatments or who have relapsed after initial treatment. Glucose intolerance can occur with the administration of Hamsyl 3750IU Injection. Contact your doctor if you experience severe headaches, abdominal pain, excessive thirst, or serious allergic reactions while taking this medicine. Patients with previous kidney and pancreatic disease should talk to their healthcare provider before taking this medication.

Uses of HAMSYL 3750IU INJECTION:

Hamsyl 3750IU Injection is indicated to treat the following conditions:

• Acute Lymphoblastic Leukemia
• Non-Hodgkin's Lymphoma

How to consume HAMSYL 3750IU INJECTION:

Hamsyl 3750IU Injection is typically administered by a healthcare provider as an intravenous (IV) injection in a clinical setting. The dosage and frequency of infusions will vary depending on the patient's medical condition, age, weight, and other factors. You should not take a double dose to make up for the second dose.